Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential

L Gao, Y Zhang, K Sterling, W Song - Translational neurodegeneration, 2022 - Springer
Synaptic abnormalities are a cardinal feature of Alzheimer's disease (AD) that are known to
arise as the disease progresses. A growing body of evidence suggests that pathological …

Recent advances on the role of brain-derived neurotrophic factor (BDNF) in neurodegenerative diseases

KF Azman, R Zakaria - International journal of molecular sciences, 2022 - mdpi.com
Neurotrophins, such as brain-derived neurotrophic factor (BDNF), are essential for neuronal
survival and growth. The signaling cascades initiated by BDNF and its receptor are the key …

Female specific risk factors for the development of Alzheimer's disease neuropathology and cognitive impairment: Call for a precision medicine approach

C Udeh-Momoh, T Watermeyer - Ageing Research Reviews, 2021 - Elsevier
Alzheimer's disease (AD) includes a long asymptomatic stage, which precedes the formal
diagnosis of dementia. AD biomarker models provide a framework for precision medicine …

[HTML][HTML] Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer's Disease …

M Lassi, C Fabbiani, S Mazzeo, R Burali, AA Vergani… - NeuroImage: Clinical, 2023 - Elsevier
Alzheimer's disease (AD) pathological changes may begin up to decades earlier than the
appearance of the first symptoms of cognitive decline. Subjective cognitive decline (SCD) …

Brothers in arms: proBDNF/BDNF and sAPPα/Aβ-signaling and their common interplay with ADAM10, TrkB, p75NTR, sortilin, and sorLA in the progression of …

S Eggert, S Kins, K Endres, T Brigadski - Biological Chemistry, 2022 - degruyter.com
Brain-derived neurotrophic factor (BDNF) is an important modulator for a variety of functions
in the central nervous system (CNS). A wealth of evidence, such as reduced mRNA and …

[HTML][HTML] Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor?

M Zagrebelsky, M Korte - Neural Regeneration Research, 2024 - journals.lww.com
Brain-derived neurotrophic factor signaling via its receptor tropomyosin receptor kinase B
regulates several crucial physiological processes. It has been shown to act in the brain …

PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol

S Mazzeo, M Lassi, S Padiglioni, AA Vergani… - BMC neurology, 2023 - Springer
Background As disease-modifying therapies (DMTs) for Alzheimer's disease (AD) are
becoming a reality, there is an urgent need to select cost-effective tools that can accurately …

Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease

M Ramezani, M Fernando, S Eslick, PR Asih… - Frontiers in …, 2023 - frontiersin.org
Alzheimer's disease (AD) is the most common form of dementia. AD is a progressive
neurodegenerative disorder characterized by cognitive dysfunction, including learning and …

Association between BDNF Val66Met polymorphism and mild behavioral impairment in patients with Parkinson's disease

M Ramezani, JA Ruskey, K Martens, M Kibreab… - Frontiers in …, 2021 - frontiersin.org
Neuropsychiatric symptoms (NPS) are common in Parkinson's disease (PD) and have
demonstrated an association with the p. Val66Met, a polymorphism in the BDNF gene. Mild …

An Interaction between Brain-Derived Neurotrophic Factor and Stress-Related Glucocorticoids in the Pathophysiology of Alzheimer's Disease

T Numakawa, R Kajihara - International Journal of Molecular Sciences, 2024 - mdpi.com
Both the brain-derived neurotrophic factor (BDNF) and glucocorticoids (GCs) play multiple
roles in various aspects of neurons, including cell survival and synaptic function. BDNF and …